Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Learn how Us Market Index Funds Retirement 2024 provides core exposure to the U.S. market. Compare funds and refine your retirement allocation.
28,197 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
CrossCountry Mortgage enters the race to acquire Two Harbors, joining a competing all cash bid and heightening a batt...
Ethereum sits around $2,170 as the scaling debate intensifies. Analysts warn that a fragmented L2 path and security c...
UBS cuts Mosaic’s price target to $27, citing squeezed phosphate margins from higher sulfur and input costs, as Wall ...
Among the market’s biggest names, only a few of the so-called magnficent seven look like buys today. This piece digs ...
In a dramatic Q1, a bold Bitcoin-focused strategy posts a $12.5 billion loss. This article explains what happened, wh...
Intel posted a stronger-than-expected Q1, yet rising costs and cash-flow strain raise the risk of a sharper pullback....
When a board member sells shares, investors watch closely. This article unpacks a recent Arteris insider move, what i...
This week brings four major earnings reports that could reveal trends in consumer spending, AI demand, and corporate ...
IonQ posted a 755% YoY jump in Q1 2026 revenue to $64.67 million, but mounting losses and burn risk cast doubt on the...
A clash between the fast-food giant’s value-menu push and a traffic-led steakhouse model drives a new look at restaur...
Renovo Management closed two senior secured notes totaling $74.5 million, earning investment-grade ratings. The deal ...